Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 94 (RPL23AP94)

Target
RPL23AP94
Molecular classification
Other (Pseudogene; not protein-coding, not a receptor, enzyme, transporter, or classical target class)
01

Overview

Ribosomal protein L23a pseudogene 94 (RPL23AP94) is a processed pseudogene located in the human genome that is derived from the parental gene encoding ribosomal protein L23a, a component of the 60S large ribosomal subunit[1][4]. Pseudogenes like RPL23AP94 are genetic sequences similar to functional genes but typically lack protein-coding potential and do not produce functional proteins[6]. There are over 90 known ribosomal protein L23a pseudogenes in the genome, all named in series from RPL23AP1 to RPL23AP97, and none including RPL23AP94 are established as protein-coding or having a direct biological role[3][5]. No disease associations, mechanistic roles, or therapeutic relevance have been reported for RPL23AP94 specifically. It is one of many processed pseudogenes that reflect gene duplication and retrotransposition events in human evolution. Research into some ribosomal pseudogenes (such as RPL23AP53) suggests possible roles as noncoding RNA regulators in disease, but such functions have not been demonstrated for RPL23AP94[5]. Therefore, it is not considered a therapeutic target, nor is it known to have interacting drugs or diagnostic biomarker roles.

Other names
RPL23AP94Ribosomal protein L23a pseudogene 94
02

Mechanism of action

None applicable; not an active molecule or recognized drug target

03

Biological functions

None known; pseudogene, no demonstrated biological function
04

Disease associations

None reported; no known direct disease associations
05

Safety considerations

None; not a drug target, not directly involved in biology or therapy
06

Interacting drugs

None reported; not a drug target
07

Biomarkers

None described for patient selection or monitoring; other RPL23A pseudogenes have been associated with some prognostic roles, but not RPL23AP94 specifically

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 94 (RPL23AP94).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 94 (RPL23AP94).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call